US 12,042,509 · Application 17/937,344 · Granted Jul 23, 2024
US 12,042,509
Prekallikrein-modulating compositions and methods of use thereof
Estimated expiration
September 30, 2042
15y 349d remaining
Earliest effective filing
Sep 30, 2022
+ 20 years
Sep 30, 2042
PTA +0d
Sep 30, 2042
No TD
—
Final
Sep 30, 2042
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- September 30, 2022
- Earliest effective filing
- September 30, 2022
- Issue date
- July 23, 2024
- PTA
- 0 days
- Base expiry (before PTA)
- September 30, 2042
September 30, 2022 + 20 years = September 30, 2042
- PRO63/287,969 — Provisional — not used for base term
- PRO63/283,175 — Provisional — not used for base term
- PRO63/270,504 — Provisional — not used for base term
- PRO63/252,554 — Provisional — not used for base term
- PRO63/251,571 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/937,344 · US 12,042,509
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,042,509: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12042509Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.